Wird geladen...
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
Inhibitory properties of PD-1 receptor engagement on activated T cells are well established in physiologic and pathological contexts. In cancer, the use of checkpoint blockade, such as anti-PD-1 antibodies, becomes progressively a reference treatment of a growing number of tumors. Nonetheless, it is...
Gespeichert in:
| Veröffentlicht in: | Oncoimmunology |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739549/ https://ncbi.nlm.nih.gov/pubmed/29296515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1364828 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|